The Food and Drug Administration Aug. 8 an end to the national shortage of sodium chloride 0.9% IV solutions products. The agency said it continues to work with manufacturers on other IV fluids still experiencing shortages. The nation's IV solutions supply was significantly impacted last year when Hurricane Helene disrupted production at a Baxter manufacturing facility in North Carolina. The company produces 60% of the country’s supply of IV solutions.

Related News Articles

Headline
Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%. According to Baxter, the products will…
Headline
After incurring damage from Hurricane Helene on Sept. 27, Baxter reports that as of Dec. 19, nearly all of its manufacturing lines in its North Cove, N.C…
Headline
Baxter has resumed production on all of its 3-liter irrigation and peritoneal dialysis solutions manufacturing lines, the company announced Dec. 5. The company…
Headline
The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and that the shortage is estimated to…
Headline
Baxter Nov. 26 announced new allocation levels for multiple IV product groups and advised customers of a one- to two-week lead time for products to flow…
Headline
Supplies of Mo-99/Tc-99M, which are medical radioisotopes used in procedures to diagnose and detect diseases including heart disease and cancer, are…